Literature DB >> 12235064

Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist.

L Lundell1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12235064      PMCID： PMC1773382          DOI： 10.1136/gut.51.4.468

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  53 in total

1.  Five- to eight-year outcome of the first laparoscopic Nissen fundoplications.

Authors:  T Bammer; R A Hinder; A Klaus; P J Klingler
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

2.  Randomized clinical trial of laparoscopic versus open fundoplication: blind evaluation of recovery and discharge period.

Authors:  G Nilsson; S Larsson; F Johnsson
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

3.  Metaplastic columnar mucosa in the cervical esophagus after esophagectomy.

Authors:  Stefan Oberg; Jan Johansson; Jörgen Wenner; Bruno Walther
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Mechanism of action of antireflux procedures.

Authors:  L Rydberg; M Ruth; L Lundell
Journal:  Br J Surg       Date:  1999-03       Impact factor: 6.939

5.  Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication.

Authors:  M K Vu; J W Straathof; P J v d Schaar; J W Arndt; J Ringers; C B Lamers; A A Masclee
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

6.  Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Authors:  L Lundell; P Miettinen; H E Myrvold; S A Pedersen; B Liedman; J G Hatlebakk; R Julkonen; K Levander; J Carlsson; M Lamm; I Wiklund
Journal:  J Am Coll Surg       Date:  2001-02       Impact factor: 6.113

7.  Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group.

Authors:  J E Bais; J F Bartelsman; H J Bonjer; M A Cuesta; P M Go; E C Klinkenberg-Knol; J J van Lanschot; J H Nadorp; A J Smout; Y van der Graaf; H G Gooszen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

8.  Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group.

Authors:  L Lundell; P Miettinen; H E Myrvold; S A Pedersen; K Thor; A Andersson; J Hattlebakk; N Havu; E Janatuinen; K Levander; B Liedman; P Nyström
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

9.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

Authors:  S J Spechler; E Lee; D Ahnen; R K Goyal; I Hirano; F Ramirez; J P Raufman; R Sampliner; T Schnell; S Sontag; Z R Vlahcevic; R Young; W Williford
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

10.  Failure of antireflux surgery: causes and management strategies.

Authors:  H J Stein; H Feussner; J R Siewert
Journal:  Am J Surg       Date:  1996-01       Impact factor: 2.565
View more
  7 in total

Review 1.  Endoscopic antireflux procedures.

Authors:  J Arts; J Tack; J P Galmiche
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

2.  Long term failure of endoscopic gastroplication (EndoCinch).

Authors:  I Schiefke; A Zabel-Langhennig; S Neumann; J Feisthammel; J Moessner; K Caca
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease.

Authors:  J Arts; D Sifrim; P Rutgeerts; A Lerut; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

4.  [Reflux esophagitis].

Authors:  I Schiefke; J Mössner; K Caca
Journal:  Internist (Berl)       Date:  2005-03       Impact factor: 0.743

5.  A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy.

Authors:  J Arts; T Lerut; P Rutgeerts; D Sifrim; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 6.  Whither surgery in the treatment of gastroesophageal reflux disease (GERD)?

Authors:  David R Urbach; Wendy J Ungar; Linda Rabeneck
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

7.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.